ATP6IP2 (ATP6AP2) Human shRNA Plasmid Kit (Locus ID 10159)
CAT#: TR314574
ATP6AP2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | ATP6IP2 (ATP6AP2) Human shRNA Plasmid Kit (Locus ID 10159) |
Locus ID | 10159 |
UniProt ID | O75787 |
Synonyms | APT6M8-9; ATP6IP2; ATP6M8-9; CDG2R; ELDF10; HT028; M8-9; MRXE; MRXSH; MSTP009; PRR; RENR; XMRE; XPDS |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | ATP6AP2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 10159). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_005765, NM_005765.1, NM_005765.2, BC084541, BC010395, NM_005765.3 |
Summary | This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
(Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations
,Wang, J;Shibayama, Y;Zhang, A;Ohsaki, H;Asano, E;Suzuki, Y;Kushida, Y;Kobara, H;Masaki, T;Wang, Z;Nishiyama, A;,
Br. J. Cancer
,PubMed ID 30555158
[ATP6AP2]
|
Documents
Product Manuals |
FAQs |
SDS |
其它ATP6AP2产品
Customer
Reviews
Loading...